Skip to Main Content
TABLE 2

Primary, Secondary, and Subgroup Outcomes

OutcomePalivizumab (n = 208)Placebo (n = 205)P
Primary outcome, n (%)    
 Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge 23 (11.0) 19 (9.3) .51 
  Children admitted to the infirmary within 3 wk after discharge 14 (6.7) 16 (7.8) .43 
  Children admitted to the hospital within 3 wk after discharge 7 (3.4) 1 (0.5) .06 
  Children admitted to the PICU within 3 wk after discharge 2 (1) 2 (1) .99 
Secondary outcomes    
 Children requiring revisits but not admission within 3 wk after discharge, n (%) 41 (19.7) 45 (22.0) .63 
  Total no. of revisits within 3 wk after discharge, n 85 94 — 
 Children transferred to the PICU during initial admission, n (%) 10 (4.8) 13 (6.3) .53 
Subgroup primary outcome    
 Index presentation after ≤1 d of symptoms, n 18 17 — 
  Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge, n (%) 3 (16.7) 1 (5.9) .31 
 Index presentation after ≤2 d of symptoms, n 78 71 — 
  Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge, n (%) 8 (10.3) 7 (9.9) .93 
 Index presentation PCR positive solely for RSV, n 142 138 — 
  Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge, n (%) 15 (10.6) 12 (8.7) .69 
OutcomePalivizumab (n = 208)Placebo (n = 205)P
Primary outcome, n (%)    
 Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge 23 (11.0) 19 (9.3) .51 
  Children admitted to the infirmary within 3 wk after discharge 14 (6.7) 16 (7.8) .43 
  Children admitted to the hospital within 3 wk after discharge 7 (3.4) 1 (0.5) .06 
  Children admitted to the PICU within 3 wk after discharge 2 (1) 2 (1) .99 
Secondary outcomes    
 Children requiring revisits but not admission within 3 wk after discharge, n (%) 41 (19.7) 45 (22.0) .63 
  Total no. of revisits within 3 wk after discharge, n 85 94 — 
 Children transferred to the PICU during initial admission, n (%) 10 (4.8) 13 (6.3) .53 
Subgroup primary outcome    
 Index presentation after ≤1 d of symptoms, n 18 17 — 
  Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge, n (%) 3 (16.7) 1 (5.9) .31 
 Index presentation after ≤2 d of symptoms, n 78 71 — 
  Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge, n (%) 8 (10.3) 7 (9.9) .93 
 Index presentation PCR positive solely for RSV, n 142 138 — 
  Children admitted to the infirmary, hospital, or PICU within 3 wk after discharge, n (%) 15 (10.6) 12 (8.7) .69 

—, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal